# Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG

> **NCT04392739** · PHASE4 · COMPLETED · sponsor: **SIGA Technologies** · enrollment: 34 (actual)

## Conditions studied

- Smallpox

## Interventions

- **DRUG:** Tpoxx

## Key facts

- **NCT ID:** NCT04392739
- **Lead sponsor:** SIGA Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-19
- **Primary completion:** 2019-12-05
- **Final completion:** 2019-12-05
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04392739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04392739, "Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT04392739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*